Yuri Quintana1,2, Eduardo A Gonzalez Martorell2, Darren Fahy1, Charles Safran1,2. 1. Division of Clinical Informatics, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States. 2. Harvard Medical School, Boston, Massachusetts, United States.
Abstract
OBJECTIVE: Adherence to antiretroviral therapy (ART) is paramount to successful long-term suppression of human immunodeficiency virus (HIV). For poorly adherent patients with HIV, barriers to remaining adherent may be overcome by the implementation of targeted interventions delivered via mobile devices. This systematic review is focused specifically on mobile phone technologies to deliver adherence interventions in HIV/acquired immunodeficiency syndrome (AIDS) populations. METHODS: This review (PROSPERO #CRD42017065131) systematically extracted data from published literature from five databases on mobile phone interventions to improve adherence to ART for HIV. The reported studies had been conducted between 2007 and 2017. Risk of bias was assessed using the Cochrane method ranking each criterion as low, high, or unclear risk of bias. RESULTS: Of the 835 articles returned, we identified 26 randomized controlled trials (RCTs), retrospective and prospective cohort trials, or mixed method studies with a comparison group that fit criteria for inclusion. No standard measure of adherence was consistent throughout the examined studies, and assessments by self-report, pill counting, and medication event monitoring system (MEMS) were utilized. The studies reported mixed results, with 17 reporting significant improvements to adherence, 3 reporting improvements without supplying p-values, and 6 reporting no significant change or a reduction in adherence. CONCLUSION: The mixed nature of the results exemplifies the need for more comprehensive approaches and larger scale trials to confirm results observed in limited cohort sizes. To better retain satisfactory adherence within the HIV population, and especially in low-resource settings, we recommend that future interventions incorporate multiple strategies: mobile-based reminders, social support structures, and personalized content. Schattauer GmbH Stuttgart.
OBJECTIVE: Adherence to antiretroviral therapy (ART) is paramount to successful long-term suppression of human immunodeficiency virus (HIV). For poorly adherent patients with HIV, barriers to remaining adherent may be overcome by the implementation of targeted interventions delivered via mobile devices. This systematic review is focused specifically on mobile phone technologies to deliver adherence interventions in HIV/acquired immunodeficiency syndrome (AIDS) populations. METHODS: This review (PROSPERO #CRD42017065131) systematically extracted data from published literature from five databases on mobile phone interventions to improve adherence to ART for HIV. The reported studies had been conducted between 2007 and 2017. Risk of bias was assessed using the Cochrane method ranking each criterion as low, high, or unclear risk of bias. RESULTS: Of the 835 articles returned, we identified 26 randomized controlled trials (RCTs), retrospective and prospective cohort trials, or mixed method studies with a comparison group that fit criteria for inclusion. No standard measure of adherence was consistent throughout the examined studies, and assessments by self-report, pill counting, and medication event monitoring system (MEMS) were utilized. The studies reported mixed results, with 17 reporting significant improvements to adherence, 3 reporting improvements without supplying p-values, and 6 reporting no significant change or a reduction in adherence. CONCLUSION: The mixed nature of the results exemplifies the need for more comprehensive approaches and larger scale trials to confirm results observed in limited cohort sizes. To better retain satisfactory adherence within the HIV population, and especially in low-resource settings, we recommend that future interventions incorporate multiple strategies: mobile-based reminders, social support structures, and personalized content. Schattauer GmbH Stuttgart.
Authors: Ann-Margaret Dunn Navarra; Marya Viorst Gwadz; Robin Whittemore; Suzanne R Bakken; Charles M Cleland; Winslow Burleson; Susan Kaplan Jacobs; Gail D'Eramo Melkus Journal: AIDS Behav Date: 2017-11
Authors: Thiago Martini da Costa; Bárbara Jaqueline Peres Barbosa; Durval Alex Gomes e Costa; Daniel Sigulem; Heimar de Fátima Marin; Adauto Castelo Filho; Ivan Torres Pisa Journal: Int J Med Inform Date: 2012-01-31 Impact factor: 4.046
Authors: Rebecca A Jeffery; Tamara Navarro; Nancy L Wilczynski; Emma C Iserman; Arun Keepanasseril; Bhairavi Sivaramalingam; Thomas Agoritsas; R Brian Haynes Journal: J Clin Epidemiol Date: 2014-07-30 Impact factor: 6.437
Authors: Grant B Ellsworth; Leah A Burke; Martin T Wells; Satish Mishra; Matthew Caffrey; David Liddle; Malika Madhava; Curtis O'Neal; Peter L Anderson; Lane Bushman; Lucas Ellison; Josh Stein; Roy M Gulick Journal: J Acquir Immune Defic Syndr Date: 2021-01-01 Impact factor: 3.771
Authors: Suzette Glasner; Helene Chokron Garneau; Alfonso Ang; Lara Ray; Alexandra Venegas; Richard Rawson; Seth Kalichman Journal: PLoS One Date: 2020-03-12 Impact factor: 3.240